| Title |
Reboxetine versus other antidepressive agents for depression
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2018
|
| DOI | 10.1002/14651858.cd007852.pub2 |
| Authors |
Rachel Churchill, Deborah M Caldwell, Hugh McGuire, Corrado Barbui, Andrea Cipriani, Toshi A Furukawa, Norio Watanabe, Glyn Lewis |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 2% |
| Canada | 1 | 2% |
| Unknown | 51 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 25% |
| Other | 9 | 17% |
| Student > Bachelor | 6 | 11% |
| Student > Ph. D. Student | 5 | 9% |
| Student > Master | 5 | 9% |
| Other | 12 | 23% |
| Unknown | 3 | 6% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 49% |
| Agricultural and Biological Sciences | 8 | 15% |
| Psychology | 4 | 8% |
| Nursing and Health Professions | 3 | 6% |
| Social Sciences | 3 | 6% |
| Other | 4 | 8% |
| Unknown | 5 | 9% |